MedTrace Logo

Pain Relief by Intra-Peritoneal Ropivacaine During Gynecological Laparoscopy

NCT00433316 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2008-06-20

No results posted yet for this study

Summary

In our prospective, randomized, placebo controlled and double-blinded study we will study the efficacy of intraperitoneal ropivacaine nebulization on pain relief during gynecological laparoscopic surgery.

Conditions

  • Laparoscopic Surgical Procedures

Interventions

DRUG

ropivacaine

1% ropivacaine

DEVICE

Aeroneb Pro Nezulizer, Aerogen, Ireland

Aeroneb Pro Nezulizer, Aerogen, Ireland

Sponsors & Collaborators

  • Carmel Medical Center

    lead OTHER

Principal Investigators

  • Yuval Kaufman, MD · Carmel Medical Center, Haifa, Israel

  • Reuven Pizov, Prof. · Carmel Medical Center, Haifa, Israel

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-28
Primary Completion
2007-10-31
Completion
2007-10-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00433316 on ClinicalTrials.gov